Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2011 (2011), Article ID 858262, 8 pages
http://dx.doi.org/10.4061/2011/858262
Review Article

Preclinical Research into Basic Mechanisms of Radiation-Induced Heart Disease

Division of Radiation Health, Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 522-10, Little Rock, AR 72205, USA

Received 15 June 2010; Accepted 4 September 2010

Academic Editor: Syed Wamique Yusuf

Copyright © 2011 M. Boerma and M. Hauer-Jensen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Verdecchia, S. Guzzinati, S. Francisci et al., “Survival trends in European cancer patients diagnosed from 1988 to 1999,” European Journal of Cancer, vol. 45, no. 6, pp. 1042–1066, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Gatta, G. Zigon, R. Capocaccia et al., “Survival of European children and young adults with cancer diagnosed 1995–2002,” European Journal of Cancer, vol. 45, no. 6, pp. 992–1005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Adams, S. R. Lipsitz, S. D. Colan et al., “Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy,” Journal of Clinical Oncology, vol. 22, no. 15, pp. 3139–3148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. A. Heidenreich, S. L. Hancock, R. H. Vagelos, B. K. Lee, and I. Schnittger, “Diastolic dysfunction after mediastinal irradiation,” American Heart Journal, vol. 150, no. 5, pp. 977–982, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. Early Breast Cancer Trialists Collaborative Group, “Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group,” The Lancet, vol. 355, pp. 1757–1770, 2000. View at Google Scholar
  6. M. J. Hooning, B. M. P. Aleman, A. J. M. van Rosmalen, M. A. Kuenen, J. G. M. Klijn, and F. E. van Leeuwen, “Cause-specific mortality in long-term survivors of breast cancer: a 25-year follow-up study,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 4, pp. 1081–1091, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. S. Chera, C. Rodriguez, C. G. Morris et al., “Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy,” International Journal of Radiation Oncology, Biology, Physics, vol. 75, no. 4, pp. 1173–1180, 2009. View at Google Scholar · View at Scopus
  8. G. F. Tillman, T. Pawlicki, A. C. Koong, and K. A. Goodman, “Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction and proximal gastric cancers: a comparison of normal tissue radiation doses,” Diseases of the Esophagus, vol. 21, no. 5, pp. 437–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. D. C. Weber, N. Peguret, G. Dipasquale, and L. Cozzi, “Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 5, pp. 1578–1586, 2009. View at Publisher · View at Google Scholar
  10. W. C. Wu, C. L. Chan, Y. W. Wong, and J. P. Cuijpers, “A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT,” British Journal of Radiology, vol. 83, no. 987, pp. 252–256, 2010. View at Publisher · View at Google Scholar
  11. P. McGale and S. C. Darby, “Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence,” Radiation Research, vol. 163, no. 3, pp. 247–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Adams, P. H. Hardenbergh, L. S. Constine, and S. E. Lipshultz, “Radiation-associated cardiovascular disease,” Critical Reviews in Oncology/Hematology, vol. 45, no. 1, pp. 55–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. McChesney, E. L. Gillette, and B. E. Powers, “Radiation-induced cardiomyopathy in the dog,” Radiation Research, vol. 113, no. 1, pp. 120–132, 1988. View at Google Scholar · View at Scopus
  14. S. Schultz-Hector and K. Balz, “Radiation-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration: an ultrastructural study,” Laboratory Investigation, vol. 71, no. 2, pp. 252–260, 1994. View at Google Scholar · View at Scopus
  15. V. V. Yang, S. P. Stearner, and S. A. Tyler, “Radiation induced changes in the fine structure of the heart: comparison of fission neutrons and 60Co γ rays in the mouse,” Radiation Research, vol. 67, no. 2, pp. 344–360, 1976. View at Google Scholar · View at Scopus
  16. J. R. Eltringham, L. F. Fajardo, and J. R. Stewart, “Adriamycin cardiomyopathy: enhanced cardiac damage in rabbits with combined drug and cardiac irradiation,” Radiology, vol. 115, no. 2, pp. 471–472, 1975. View at Google Scholar · View at Scopus
  17. O. Labudova, R. Hardmeier, H. Rink, and G. Lubec, “The transcription of the XRCC1 gene in the heart of radiation-resistant and radiation-sensitive mice after ionizing irradiation,” Pediatric Research, vol. 41, no. 3, pp. 435–439, 1997. View at Google Scholar · View at Scopus
  18. S. Schultz-Hector and K.-R. Trott, “Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?” International Journal of Radiation Oncology Biology Physics, vol. 67, no. 1, pp. 10–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hoving, S. Heeneman, M. J. J. Gijbels et al., “Single-dose and fractionated irradiation promote initiation and progression of atherosclerosis and induce an inflammatory plaque phenotype in ApoE(-/-) Mice,” International Journal of Radiation Oncology Biology Physics, vol. 71, no. 3, pp. 848–857, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. F. A. Stewart, S. Heeneman, J. Te Poele et al., “Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE(-/-) mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage,” American Journal of Pathology, vol. 168, no. 2, pp. 649–658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Lauk and K.-R. Trott, “Radiation induced heart disease in hypertensive rats,” International Journal of Radiation Oncology Biology Physics, vol. 14, no. 1, pp. 109–114, 1988. View at Google Scholar · View at Scopus
  22. H. Gold, “Atherosclerosis in the rat. Effect of x-ray and a high fat diet,” Proceedings of the Society for Experimental Biology and Medicine, vol. 111, pp. 593–595, 1962. View at Google Scholar
  23. T. Kitahara, K. Liu, K. Solanki, and K. R. Trott, “Functional and morphological damage after local heart irradiation and/or adriamycin in Wistar rats,” Radiation Oncology Investigations, vol. 1, pp. 198–205, 1993. View at Google Scholar
  24. J. J. C. M. Krüse, C. Zurcher, E. G. Strootman et al., “Structural changes in the auricles of the rat heart after local ionizing irradiation,” Radiotherapy and Oncology, vol. 58, no. 3, pp. 303–311, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Lauk, Z. Kiszel, J. Buschmann, and K.-R. Trott, “Radiation-induced heart disease in rats,” International Journal of Radiation Oncology Biology Physics, vol. 11, no. 4, pp. 801–808, 1985. View at Google Scholar · View at Scopus
  26. S. Hu, Y. Chen, L. Li et al., “Effects of adenovirus-mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 5, pp. 1537–1544, 2009. View at Publisher · View at Google Scholar
  27. L. F. Fajardo and J. R. Stewart, “Pathogenesis of radiation induced myocardial fibrosis,” Laboratory Investigation, vol. 29, no. 2, pp. 244–257, 1973. View at Google Scholar · View at Scopus
  28. J. P. Veinot and W. D. Edwards, “Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases,” Human Pathology, vol. 27, no. 8, pp. 766–773, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. F. C. Brosius III, B. F. Waller, and W. C. Roberts, “Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart,” American Journal of Medicine, vol. 70, no. 3, pp. 519–530, 1981. View at Google Scholar · View at Scopus
  30. A. Hamza, P. A. Tunick, and I. Kronzon, “Echocardiographic manifestations of complications of radiation therapy,” Echocardiography, vol. 26, no. 6, pp. 724–728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. P. Little, E. J. Tawn, I. Tzoulaki et al., “A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms,” Radiation Research, vol. 169, no. 1, pp. 99–109, 2008. View at Publisher · View at Google Scholar
  32. L. F. Fajardo and J. R. Stewart, “Capillary injury preceding radiation-induced myocardial fibrosis,” Radiology, vol. 101, no. 2, pp. 429–433, 1971. View at Google Scholar · View at Scopus
  33. J. E. Baker, B. L. Fish, J. Su et al., “10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model,” International Journal of Radiation Biology, vol. 85, no. 12, pp. 1089–1100, 2009. View at Publisher · View at Google Scholar
  34. S. Lauk and K.-R. Trott, “Endothelial cell proliferation in the rat heart following local heart irradiation,” International Journal of Radiation Biology, vol. 57, no. 5, pp. 1017–1030, 1990. View at Google Scholar · View at Scopus
  35. M. Boerma, J. J. C. M. Kruse, M. M. Van Loenen et al., “Increased deposition of von willebrand factor in the rat heart after local Ionizing irradiation,” Strahlentherapie und Onkologie, vol. 180, no. 2, pp. 109–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Boerma, K. A. Roberto, and M. Hauer-Jensen, “Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 1, pp. 170–177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. J. J. C. M. Krüse, C. I. Bart, A. Visser, and J. Wondergem, “Changes in transforming growth factor-β (TGF-β1), procollagen types I and III mRNA in the rat heart after irradiation,” International Journal of Radiation Biology, vol. 75, no. 11, pp. 1429–1436, 1999. View at Google Scholar · View at Scopus
  38. H. Liu, M. Xiong, Y.-F. Xia et al., “Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 5, pp. 1552–1559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Wu and Y. Zeng, “Does angiotensin II-aldosterone have a role in radiation-induced heart disease?” Medical Hypotheses, vol. 72, no. 3, pp. 263–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Yarom, I. S. Harper, S. Wynchank et al., “Effect of captopril on changes in rats' hearts induced by long-term irradiation,” Radiation Research, vol. 133, no. 2, pp. 187–197, 1993. View at Google Scholar · View at Scopus
  41. M. Boerma, J. Wang, J. Wondergem et al., “Influence of mast cells on structural and functional manifestations of radiation-induced heart disease,” Cancer Research, vol. 65, no. 8, pp. 3100–3107, 2005. View at Google Scholar · View at Scopus
  42. J. Wang, M. Boerma, Q. Fu, and M. Hauer-Jensen, “Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy,” World Journal of Gastroenterology, vol. 13, no. 22, pp. 3047–3055, 2007. View at Google Scholar · View at Scopus
  43. J. W. Hopewell, W. Calvo, R. Jaenke, H. S. Reinhold, M. E. Robbins, and E. M. Whitehouse, “Microvasculature and radiation damage,” Recent Results in Cancer Research, vol. 130, pp. 1–16, 1993. View at Google Scholar · View at Scopus
  44. J. W. Denham and M. Hauer-Jensen, “The radiotherapeutic injury—a complex 'wound',” Radiotherapy and Oncology, vol. 63, no. 2, pp. 129–145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. C. M. Kruse, B. G. J. Floot, J. A. M. te Poele, N. S. Russell, and F. A. Stewart, “Radiation-nduced activation of TGF-β signaling pathways in relation to vascular damage in mouse kidneys,” Radiation Research, vol. 171, no. 2, pp. 188–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Scharpfenecker, J. J. C. M. Kruse, D. Sprong, N. S. Russell, P. ten Dijke, and F. A. Stewart, “Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 506–513, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. H. P. Rodemann, A. Binder, A. Burger, N. Guven, H. Loffler, and M. Bamberg, “The underlying cellular mechanism of fibrosis,” Kidney International, Supplement, no. 54, pp. S32–S36, 1996. View at Google Scholar · View at Scopus
  48. K. K. Richter, C. W. Langberg, C.-C. Sung, and M. Hauer-Jensen, “Association of transforming growth factor β (TGF-β) immunoreactivity with specific histopathologic lesions in subacute and chronic experimental radiation enteropathy,” Radiotherapy and Oncology, vol. 39, no. 3, pp. 243–251, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. M. H. Barcellos-Hoff, “How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues,” Radiation Research, vol. 150, no. 5, pp. S109–S120, 1998. View at Google Scholar · View at Scopus
  50. J. Kalesnikoff and S. J. Galli, “New developments in mast cell biology,” Nature Immunology, vol. 9, no. 11, pp. 1215–1223, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Gottwald, S. Coerper, M. Schäffer, G. Köveker, and R. H. Stead, “The mast cell-nerve axis in wound healing: a hypothesis,” Wound Repair and Regeneration, vol. 6, no. 1, pp. 8–20, 1998. View at Google Scholar · View at Scopus
  52. E. Crivellato, C. A. Beltrami, F. Mallardi, and D. Ribatti, “The mast cell: an active participant or an innocent bystander?” Histology and Histopathology, vol. 19, no. 1, pp. 259–270, 2004. View at Google Scholar · View at Scopus
  53. S. J. Galli, J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. M. Williams, and M. Tsai, “Mast cells as “tunable” effector and immunoregulatory cells: recent advances,” Annual Review of Immunology, vol. 23, pp. 749–786, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. P. K. Koskinen, P. T. Kovanen, K. A. Lindstedt, and K. B. Lemström, “Mast cells in acute and chronic rejection of rat cardiac allografts—a major source of basic fibroblast growth factor,” Transplantation, vol. 71, no. 12, pp. 1741–1747, 2001. View at Google Scholar · View at Scopus
  55. Q.-Y. Li, A. Raza-Ahmad, M. A. MacAulay et al., “The relationship of mast cells and their secreted products to the volume of fibrosis in posttransplant hearts,” Transplantation, vol. 53, no. 5, pp. 1047–1051, 1992. View at Google Scholar · View at Scopus
  56. M. Boerma, C. Zurcher, I. Esveldt, C. I. Schutte-Bart, and J. Wondergem, “Histopathology of ventricles, coronary arteries and mast cell accumulation in transverse and longitudinal sections of the rat heart after irradiation,” Oncology Reports, vol. 12, no. 2, pp. 213–219, 2004. View at Google Scholar · View at Scopus
  57. E. N. Geissler and E. S. Russell, “Analysis of the hematopoietic effects of new dominant spotting (W) mutations of the mouse. II. Effects on mast cell development,” Experimental Hematology, vol. 11, no. 6, pp. 461–466, 1983. View at Google Scholar · View at Scopus
  58. Y. Kitamura and S. Go, “Decreased production of mast cells in S1/S1(d) anemic mice,” Blood, vol. 53, no. 3, pp. 492–497, 1979. View at Google Scholar · View at Scopus
  59. Y. Kitamura, S. Go, and K. Hatanaka, “Decrease of mast cells in W/W(V) mice and their increase by bone marrow transplantation,” Blood, vol. 52, no. 2, pp. 447–452, 1978. View at Google Scholar · View at Scopus
  60. T. Tsujimura, S. Hirota, S. Nomura et al., “Characterization of Ws mutant allele of rats: a 12-base deletion in tyrosine kinase domain of c-kit gene,” Blood, vol. 78, no. 8, pp. 1942–1946, 1991. View at Google Scholar · View at Scopus
  61. K. Horiguchi and T. Komuro, “Ultrastructural characterization of interstitial cells of Cajal in the rat small intestine using control and Ws/Ws mutant rats,” Cell and Tissue Research, vol. 293, no. 2, pp. 277–284, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Boerma, W. P. Fiser, G. Hoyt et al., “Influence of mast cells on outcome after heterotopic cardiac transplantation in rats,” Transplant International, vol. 20, no. 3, pp. 256–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Joseph, R. H. Kennedy, S. Devi, J. Wang, L. Joseph, and M. Hauer-Jensen, “Protective role of mast cells in homocysteine-induced cardiac remodeling,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 288, no. 5, pp. H2541–H2545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Ehrenreich, P. R. Burd, M. Rottem et al., “Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines,” The New Biologist, vol. 4, no. 2, pp. 147–156, 1992. View at Google Scholar · View at Scopus
  65. L. A. Schneider, S. M. Schlenner, T. B. Feyerabend, M. Wunderlin, and H.-R. Rodewald, “Molecular mechanism of mast cell-mediated innate defense against endothelin and snake venom sarafotoxin,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2629–2639, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. E. Simard, D. Jin, S. Takai, M. Miyazaki, I. Brochu, and P. D'Orléans-Juste, “Chymase-dependent conversion of big endothelin-1 in the mouse in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 2, pp. 540–548, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Maurer, J. Wedemeyer, M. Metz et al., “Mast cells promote homeostasis by limiting endothelin-1-induced toxicity,” Nature, vol. 432, no. 7016, pp. 512–516, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. K. P. Metsärinne, P. Vehmaan-Kreula, P. T. Kovanen et al., “Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted peptide,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 2, pp. 268–273, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. L. L. Yang, S. Arab, P. Liu, D. J. Stewart, and M. Husain, “The role of endothelin-1 in myocarditis and inflammatory cardiomyopathy: old lessons and new insights,” Canadian Journal of Physiology and Pharmacology, vol. 83, no. 1, pp. 47–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. R. M. Kedzierski and M. Yanagisawa, “Endothelin system: the double-edged sword in health and disease,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 851–876, 2001. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Cernacek, D. J. Stewart, J.-C. Monge, and J.-L. Rouleau, “The endothelin system and its role in acute myocardial infarction,” Canadian Journal of Physiology and Pharmacology, vol. 81, no. 6, pp. 598–606, 2003. View at Publisher · View at Google Scholar · View at Scopus
  72. G. Ertl and J. Bauersachs, “Endothelin receptor antagonists in heart failure: current status and future directions,” Drugs, vol. 64, no. 10, pp. 1029–1040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Giannessi, S. Del Ry, and R. L. Vitale, “The role of endothelins and their receptors in heart failure,” Pharmacological Research, vol. 43, no. 2, pp. 111–126, 2001. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Sakai, T. Miyauchi, T. Sakurai et al., “Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart,” Circulation, vol. 93, no. 6, pp. 1214–1222, 1996. View at Google Scholar · View at Scopus
  75. J. Piuhola, I. Szokodi, P. Kinnunen et al., “Endothelin-1 contributes to the Frank-Starling response in hypertrophic rat hearts,” Hypertension, vol. 41, no. 1, pp. 93–98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Miyauchi and T. Masaki, “Pathophysiology of endothelin in the cardiovascular system,” Annual Review of Physiology, vol. 61, pp. 391–415, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. H. Yamamura, T. Nabe, S. Kohno, and K. Ohata, “Endothelin-1 induces release of histamine and leukotriene C4 from mouse bone marrow-derived mast cells,” European Journal of Pharmacology, vol. 257, no. 3, pp. 235–242, 1994. View at Publisher · View at Google Scholar · View at Scopus
  78. J. S. Janicki, G. L. Brower, J. D. Gardner et al., “Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload,” Cardiovascular Research, vol. 69, no. 3, pp. 657–665, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Lundequist, M. Åbrink, and G. Pejler, “Mast cell-dependent activation of pro matrix metalloprotease 2: a role for serglycin proteoglycan-dependent mast cell proteases,” Biological Chemistry, vol. 387, no. 10-11, pp. 1513–1519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  80. D. B. Murray, J. D. Gardner, G. L. Brower, and J. S. Janicki, “Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 3, pp. H1251–H1257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Boerma, J. Wang, A. Kulkarni et al., “Influence of endothelin 1 receptor inhibition on functional, structural and molecular changes in the rat heart after irradiation,” Radiation Research, vol. 170, no. 3, pp. 275–283, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Jullien, K. Blirando, F. Milliat, J.-C. Sabourin, M. Benderitter, and A. François, “Up-regulation of endothelin type a receptor in human and rat radiation proctitish preclinical therapeutic approach with endothelin receptor blockade,” International Journal of Radiation Oncology Biology Physics, vol. 74, no. 2, pp. 528–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Piuhola, M. Mäkinen, I. Szokodi, and H. Ruskoaho, “Dual role of endothelin-1 via ETA and ETB receptors in regulation of cardiac contractile function in mice,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 285, no. 1, pp. H112–H118, 2003. View at Google Scholar · View at Scopus
  84. M. Clozel, G. A. Gray, V. Breu, B.-M. Loffler, and R. Osterwalder, “The endothelin ET(B) receptor mediates both vasodilation and vasoconstriction in vivo,” Biochemical and Biophysical Research Communications, vol. 186, no. 2, pp. 867–873, 1992. View at Publisher · View at Google Scholar · View at Scopus
  85. R. M. Williams, J. Bienenstock, and R. H. Stead, “Mast cells: the neuroimmune connection,” Chemical Immunology, vol. 61, pp. 208–235, 1995. View at Google Scholar · View at Scopus
  86. N. Arizono, S. Matsuda, T. Hattori, Y. Kojima, T. Maeda, and S. J. Galli, “Anatomical variation in mast cell nerve associations in the rat small intestine, heart, lung, and skin. Similarities of distances between neural processes and mast cells, eosinophils, or plasma cells in the jejunal lamina propria,” Laboratory Investigation, vol. 62, no. 5, pp. 626–634, 1990. View at Google Scholar · View at Scopus
  87. P. Laine, A. Naukkarinen, L. Heikkilä, A. Penttilä, and P. T. Kovanen, “Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries,” Circulation, vol. 101, no. 14, pp. 1665–1669, 2000. View at Google Scholar · View at Scopus
  88. S. D. Skaper, M. Pollock, and L. Facci, “Mast cells differentially express and release active high molecular weight neurotrophins,” Molecular Brain Research, vol. 97, no. 2, pp. 177–185, 2001. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Ito, K.-I. Kawahara, K. Okamoto et al., “Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 10, pp. 1825–1830, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. W. Schulze and M. L. X. Fu, “Localization of α1-adrenoceptors in rat and human hearts by immunocytochemistry,” Molecular and Cellular Biochemistry, vol. 163-164, pp. 159–165, 1996. View at Google Scholar · View at Scopus
  91. L. J. Kay and P. T. Peachell, “Mast cell β2-adrenoceptors,” Chemical Immunology and Allergy, vol. 87, pp. 145–153, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Facoetti, S. Fallarini, S. Miserere et al., “Histochemical study of cardiac mast cells degranulation and collagen deposition: interaction with the cathecolaminergic system in the rat,” European Journal of Histochemistry, vol. 50, no. 2, pp. 133–140, 2006. View at Google Scholar · View at Scopus
  93. A.-M. Reynier-Rebuffel, P. Mathiau, J. Callebert et al., “Substance P, calcitonin gene-related peptide, and capsaicin release serotonin from cerebrovascular mast cells,” American Journal of Physiology, vol. 267, no. 5, pp. R1421–R1429, 1994. View at Google Scholar · View at Scopus
  94. G. H. Shen, L. Grundemar, Z. Zukowska-Grojec, R. Haakanson, and C. Wahlestedt, “C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents,” European Journal of Pharmacology, vol. 204, no. 3, pp. 249–256, 1991. View at Google Scholar · View at Scopus
  95. L. Grundemar, C. Wahlestedt, G. H. Shen, Z. Zukowska-Grojec, and R. Hakanson, “Biphasic blood pressure response to neuropeptide Y in anesthetized rats,” European Journal of Pharmacology, vol. 179, no. 1-2, pp. 83–87, 1990. View at Google Scholar · View at Scopus
  96. C. Arzubiaga, J. Morrow, L. J. Roberts II, and I. Biaggioni, “Neuropeptide Y, a putative cotransmitter in noradrenergic neurons, induces mast cell degranulation but not prostaglandin D2 release,” Journal of Allergy and Clinical Immunology, vol. 87, pp. 88–93, 1991. View at Google Scholar · View at Scopus
  97. M. Moriyama, T. Sato, H. Inoue et al., “The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells,” Journal of Experimental Medicine, vol. 202, no. 2, pp. 217–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. X.-Y. Hua, S. M. Back, and E. K. Tam, “Substance P enhances electrical field stimulation-induced mast cell degranulation in rat trachea,” American Journal of Physiology, vol. 270, no. 6, pp. L985–L991, 1996. View at Google Scholar · View at Scopus
  99. J. Janiszewski, J. Bienenstock, and M. G. Blennerhassett, “Picomolar doses of substance P trigger electrical responses in mast cells without degranulation,” American Journal of Physiology, vol. 267, no. 1, pp. C138–C145, 1994. View at Google Scholar · View at Scopus
  100. L. G. Morgan, S. P. Levick, T. G. Voloshenyuk et al., “A novel technique for isolating functional mast cells from the heart,” Inflammation Research, vol. 57, no. 5, pp. 241–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. Y. Saavedra and P. Vergara, “Somatostatin inhibits intestinal mucosal mast cell degranulation in normal conditions and during mast cell hyperplasia,” Regulatory Peptides, vol. 111, no. 1–3, pp. 67–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. N. Tunçel, F. Töre, V. Sahintürk, D. Ak, and M. Tunçel, “Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock,” Peptides, vol. 21, no. 1, pp. 81–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Leon, A. Buriani, R. Dal Toso et al., “Mast cells synthesize, store, and release nerve growth factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 9, pp. 3739–3743, 1994. View at Google Scholar · View at Scopus
  104. C. U. Corvera, O. Déry, K. McConalogue et al., “Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2,” Journal of Physiology, vol. 517, no. 3, pp. 741–756, 1999. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Saito and N. W. Bunnett, “Protease-activated receptors: regulation of neuronal function,” NeuroMolecular Medicine, vol. 7, no. 1-2, pp. 79–99, 2005. View at Google Scholar · View at Scopus
  106. T. Csont, C. Csonka, P. Kovács, G. Jancsó, and P. Ferdinandy, “Capsaicin-sensitive sensory neurons regulate myocardial nitric oxide and cGMP signaling,” European Journal of Pharmacology, vol. 476, no. 1-2, pp. 107–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. J. J. Preibisz, “Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis,” American Journal of Hypertension, vol. 6, no. 5 I, pp. 434–450, 1993. View at Google Scholar · View at Scopus
  108. Y.-J. Li and J. Peng, “The cardioprotection of calcitonin gene-related peptide-mediated preconditioning,” European Journal of Pharmacology, vol. 442, no. 3, pp. 173–177, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Katona, K. Boros, P. Sántha, P. Ferdinandy, M. Dux, and G. Jancsó, “Selective sensory denervation by capsaicin aggravates adriamycin-induced cardiomyopathy in rats,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 370, no. 6, pp. 436–443, 2004. View at Publisher · View at Google Scholar · View at Scopus
  110. N. Harada and K. Okajima, “Effect of capsaicin on plasma and tissue levels of insulin-like growth factor-I in spontaneously hypertensive rats,” Growth Hormone and IGF Research, vol. 18, no. 1, pp. 75–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. J. Peng, J. Xiao, F. Ye, H.-W. Deng, and Y.-J. Li, “Inhibition of cardiac tumor necrosis factor-α production by calcitonin gene-related peptide-mediated ischemic preconditioning in isolated rat hearts,” European Journal of Pharmacology, vol. 407, no. 3, pp. 303–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  112. K. H. Limesand, S. Said, and S. M. Anderson, “Suppression of radiation-induced salivary gland dysfunction by IGF-1,” PLoS ONE, vol. 4, no. 3, Article ID e4663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. X. W. Huang, J. Yang, A. F. Dragovic, H. Zhang, T. S. Lawrence, and M. Zhang, “Antisense oligonucleotide inhibition of tumor necrosis factor receptor 1 protects the liver from radiation-induced apoptosis,” Clinical Cancer Research, vol. 12, no. 9, pp. 2849–2855, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. J. Wang, X. Qiu, A. Kulkarni, and M. Hauer-Jensen, “Calcitonin gene-related peptide and substance P regulate the intestinal radiation response,” Clinical Cancer Research, vol. 12, no. 13, pp. 4112–4118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. M. E. Robbins and D. I. Diz, “Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 1, pp. 6–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. J. E. Moulder, B. L. Fish, and E. P. Cohen, “Treatment of radiation nephropathy with ACE inhibitors and aII type-1 and type-2 receptor antagonists,” Current Pharmaceutical Design, vol. 13, no. 13, pp. 1317–1325, 2007. View at Publisher · View at Google Scholar · View at Scopus
  117. M. E. Robbins, V. Payne, E. Tommasi et al., “The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiationinduced cognitive impairment,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 499–505, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Molteni, J. E. Moulder, E. F. Cohen et al., “Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker,” International Journal of Radiation Biology, vol. 76, no. 4, pp. 523–532, 2000. View at Google Scholar · View at Scopus
  119. J. E. Moulder, B. L. Fish, and E. P. Cohen, “Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy,” International Journal of Radiation Biology, vol. 73, no. 4, pp. 415–421, 1998. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Molteni, L. F. Wolfe, W. F. Ward et al., “Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-β (TGF-β) and α-Actomyosin (α SMA), important mediators of radiation-induced pneumopathy and lung fibrosis,” Current Pharmaceutical Design, vol. 13, no. 13, pp. 1307–1316, 2007. View at Publisher · View at Google Scholar
  121. W. F. Ward, A. Molteni, C. Ts'ao, and J. M. Hinz, “The effect of Captopril on benign and malignant reactions in irradiated rat skin,” British Journal of Radiology, vol. 63, no. 749, pp. 349–354, 1990. View at Google Scholar · View at Scopus
  122. I. Fleming, “Signaling by the angiotensin-converting enzyme,” Circulation Research, vol. 98, no. 1, pp. 887–896, 2006. View at Google Scholar
  123. M. K. Koike, C. De Carvalho Frimm, and M. De Lourdes Higuchi, “Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats,” Clinical and Experimental Pharmacology and Physiology, vol. 32, no. 12, pp. 1131–1136, 2005. View at Publisher · View at Google Scholar
  124. N. N. Kim, S. Villegas, S. R. Summerour, and F. J. Villarreal, “Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide,” Journal of Molecular and Cellular Cardiology, vol. 31, no. 2, pp. 457–466, 1999. View at Publisher · View at Google Scholar · View at Scopus
  125. Y. Tanaka, M. Nagai, T. Date et al., “Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats,” Hypertension Research, vol. 27, no. 11, pp. 865–875, 2004. View at Publisher · View at Google Scholar · View at Scopus
  126. H. Yin, L. Chao, and J. Chao, “Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion,” Life Sciences, vol. 82, no. 3-4, pp. 156–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  127. T. Imamura, A. Dubin, W. Moore, R. Tanaka, and J. Travis, “Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens,” Laboratory Investigation, vol. 74, no. 5, pp. 861–870, 1996. View at Google Scholar · View at Scopus
  128. L. G. Coffman, J. C. Brown, D. A. Johnson et al., “Cleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 3, pp. L505–L515, 2008. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Miyazaki and S. Takai, “Tissue angiotensin II generating system by angiotensin-converting enzyme and chymase,” Journal of Pharmacological Sciences, vol. 100, no. 5, pp. 391–397, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Lundequist, E. Tchougounova, M. Åbrink, and G. Pejler, “Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32339–32344, 2004. View at Publisher · View at Google Scholar · View at Scopus